Wahlstrom Mats bought TLSI
May 15, 2026 · Form 4 insider transaction
Wahlstrom Mats bought 60,000 shares of TriSalus Life Sciences, Inc. at $2.53 per share, a transaction worth $151.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$2.53
Total value
$151.8K
InsiderWahlstrom Mats
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 15, 2026
Filing dateMay 18, 2026
Shares owned after147,555
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.56 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.